154 related articles for article (PubMed ID: 12213789)
1. Constitutively unmasked CD22 on B cells of ST6Gal I knockout mice: novel sialoside probe for murine CD22.
Collins BE; Blixt O; Bovin NV; Danzer CP; Chui D; Marth JD; Nitschke L; Paulson JC
Glycobiology; 2002 Sep; 12(9):563-71. PubMed ID: 12213789
[TBL] [Abstract][Full Text] [Related]
2. Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact.
Collins BE; Blixt O; DeSieno AR; Bovin N; Marth JD; Paulson JC
Proc Natl Acad Sci U S A; 2004 Apr; 101(16):6104-9. PubMed ID: 15079087
[TBL] [Abstract][Full Text] [Related]
3. High-affinity ligand probes of CD22 overcome the threshold set by cis ligands to allow for binding, endocytosis, and killing of B cells.
Collins BE; Blixt O; Han S; Duong B; Li H; Nathan JK; Bovin N; Paulson JC
J Immunol; 2006 Sep; 177(5):2994-3003. PubMed ID: 16920935
[TBL] [Abstract][Full Text] [Related]
4. The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and alpha 2-6 sialyltransferase, CD75, on B cells.
Stamenkovic I; Sgroi D; Aruffo A; Sy MS; Anderson T
Cell; 1991 Sep; 66(6):1133-44. PubMed ID: 1717156
[TBL] [Abstract][Full Text] [Related]
5. Binding of human plasma sialoglycoproteins by the B cell-specific lectin CD22. Selective recognition of immunoglobulin M and haptoglobin.
Hanasaki K; Powell LD; Varki A
J Biol Chem; 1995 Mar; 270(13):7543-50. PubMed ID: 7706301
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of a multivalent homing device for targeting to murine CD22.
Sliedregt LA; van Rossenberg SM; Autar R; Valentijn AR; van der Marel GA; van Boom JH; Piperi C; van der Merwe PA; Kuiper J; van Berkel TJ; Biessen EA
Bioorg Med Chem; 2001 Jan; 9(1):85-97. PubMed ID: 11197350
[TBL] [Abstract][Full Text] [Related]
7. Sialylation of the B lymphocyte molecule CD22 by alpha 2,6-sialyltransferase is implicated in the regulation of CD22-mediated adhesion.
Braesch-Andersen S; Stamenkovic I
J Biol Chem; 1994 Apr; 269(16):11783-6. PubMed ID: 8163475
[TBL] [Abstract][Full Text] [Related]
8. The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound.
Kelm S; Gerlach J; Brossmer R; Danzer CP; Nitschke L
J Exp Med; 2002 May; 195(9):1207-13. PubMed ID: 11994426
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of the murine homologue of CD22, a B lymphocyte-restricted adhesion molecule.
Torres RM; Law CL; Santos-Argumedo L; Kirkham PA; Grabstein K; Parkhouse RM; Clark EA
J Immunol; 1992 Oct; 149(8):2641-9. PubMed ID: 1401903
[TBL] [Abstract][Full Text] [Related]
10. CD22-mediated cell adhesion to cytokine-activated human endothelial cells. Positive and negative regulation by alpha 2-6-sialylation of cellular glycoproteins.
Hanasaki K; Varki A; Powell LD
J Biol Chem; 1995 Mar; 270(13):7533-42. PubMed ID: 7706300
[TBL] [Abstract][Full Text] [Related]
11. Ablation of CD22 in ligand-deficient mice restores B cell receptor signaling.
Collins BE; Smith BA; Bengtson P; Paulson JC
Nat Immunol; 2006 Feb; 7(2):199-206. PubMed ID: 16369536
[TBL] [Abstract][Full Text] [Related]
12. A novel subset of murine B cells that expresses unmasked forms of CD22 is enriched in the bone marrow: implications for B-cell homing to the bone marrow.
Floyd H; Nitschke L; Crocker PR
Immunology; 2000 Nov; 101(3):342-7. PubMed ID: 11106937
[TBL] [Abstract][Full Text] [Related]
13. The oligosaccharide binding specificities of CD22 beta, a sialic acid-specific lectin of B cells.
Powell LD; Varki A
J Biol Chem; 1994 Apr; 269(14):10628-36. PubMed ID: 8144652
[TBL] [Abstract][Full Text] [Related]
14. CD22-Binding Synthetic Sialosides Regulate B Lymphocyte Proliferation Through CD22 Ligand-Dependent and Independent Pathways, and Enhance Antibody Production in Mice.
Matsubara N; Imamura A; Yonemizu T; Akatsu C; Yang H; Ueki A; Watanabe N; Abdu-Allah H; Numoto N; Takematsu H; Kitazume S; Tedder TF; Marth JD; Ito N; Ando H; Ishida H; Kiso M; Tsubata T
Front Immunol; 2018; 9():820. PubMed ID: 29725338
[TBL] [Abstract][Full Text] [Related]
15. Interaction of CD22 with alpha2,6-linked sialoglycoconjugates: innate recognition of self to dampen B cell autoreactivity?
Lanoue A; Batista FD; Stewart M; Neuberger MS
Eur J Immunol; 2002 Feb; 32(2):348-55. PubMed ID: 11807774
[TBL] [Abstract][Full Text] [Related]
16. A single N-linked glycosylation site is implicated in the regulation of ligand recognition by the I-type lectins CD22 and CD33.
Sgroi D; Nocks A; Stamenkovic I
J Biol Chem; 1996 Aug; 271(31):18803-9. PubMed ID: 8702538
[TBL] [Abstract][Full Text] [Related]
17. Regulation of CD45 engagement by the B-cell receptor CD22.
Sgroi D; Koretzky GA; Stamenkovic I
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):4026-30. PubMed ID: 7537381
[TBL] [Abstract][Full Text] [Related]
18. Identification of the ligand-binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid-dependent ligand.
Engel P; Wagner N; Miller AS; Tedder TF
J Exp Med; 1995 Apr; 181(4):1581-6. PubMed ID: 7535343
[TBL] [Abstract][Full Text] [Related]
19. A structure-function study of ligand recognition by CD22beta.
van Rossenberg SM; Sliedregt LA; Autar R; Piperi C; Van Der Merwe AP; van Berkel TJ; Kuiper J; Biessen EA
J Biol Chem; 2001 Apr; 276(16):12967-73. PubMed ID: 11152460
[TBL] [Abstract][Full Text] [Related]
20. Natural ligands of the B cell adhesion molecule CD22 beta can be masked by 9-O-acetylation of sialic acids.
Sjoberg ER; Powell LD; Klein A; Varki A
J Cell Biol; 1994 Jul; 126(2):549-62. PubMed ID: 8034751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
